Impact BioMedical Management
Management criteria checks 0/4
Impact BioMedical's CEO is Frank Heuszel, appointed in Apr 2023, has a tenure of 1.5 years. directly owns 0.83% of the company’s shares, worth $206.23K. The average tenure of the management team and the board of directors is 1.5 years and 2.6 years respectively.
Key information
Frank Heuszel
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.5yrs |
CEO ownership | 0.8% |
Management average tenure | 1.5yrs |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO
Frank Heuszel (68 yo)
1.5yrs
Tenure
Mr. Frank D. Heuszel, JD, Esq. serves as Chairman of the Board at Impact BioMedical Inc. He serves as the Chief Executive Officer at Impact BioMedical Inc. since April 2023 and Director since August 2020 a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 1.5yrs | no data | 0.83% $ 206.2k | |
CFO. Secretary & Treasurer | 3.8yrs | no data | 0.0010% $ 260.8 | |
Chief Operating Officer | 1.2yrs | no data | no data |
1.5yrs
Average Tenure
63yo
Average Age
Experienced Management: IBO's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 4.2yrs | no data | 0.83% $ 206.2k | |
Director | 3.8yrs | no data | no data | |
Independent Director | no data | no data | no data | |
Director | less than a year | no data | 0.0016% $ 392.4 | |
Independent Director | no data | no data | no data | |
Independent Director | no data | no data | no data | |
Director | 1.4yrs | no data | no data |
2.6yrs
Average Tenure
64yo
Average Age
Experienced Board: IBO's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.